Clin Mol Hepatol.
2021 Jan;27(1):83-86. 10.3350/cmh.2020.0298.
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
- Affiliations
-
- 1Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Key Lab of Pediatric Gastroenterology and Nutrition, Shanghai, China
- 2Department of Oncology, the First Affiliated Hospital, Institute for Liver Diseases of Anhui Medical University, Hefei, China
- KMID: 2511453
- DOI: http://doi.org/10.3350/cmh.2020.0298
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Nonalcoholic fatty liver disease: pathogenesis and treatment
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
- The crosstalk between insulin resistance and nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?
- Clinical Predictors Reflecting the Pathologic Severity of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver
